Filing metadata

Accession number
0001209191-22-057395
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Nov 16, 2022
Reporting period
Nov 14, 2022
Description
Insider transaction

Explore SEC Filings Hub